SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 10 filers reported holding SEATTLE GENETICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $702,216 | +32.7% | 3,310 | +20.4% | 0.04% | +37.9% |
Q2 2023 | $529,265 | -4.9% | 2,750 | 0.0% | 0.03% | -12.1% |
Q1 2023 | $556,792 | +57.6% | 2,750 | 0.0% | 0.03% | +50.0% |
Q4 2022 | $353,402 | -6.0% | 2,750 | 0.0% | 0.02% | -15.4% |
Q3 2022 | $376,000 | -22.8% | 2,750 | 0.0% | 0.03% | -18.8% |
Q2 2022 | $487,000 | +23.0% | 2,750 | 0.0% | 0.03% | +45.5% |
Q1 2022 | $396,000 | -6.8% | 2,750 | 0.0% | 0.02% | +4.8% |
Q4 2021 | $425,000 | -9.0% | 2,750 | 0.0% | 0.02% | -19.2% |
Q3 2021 | $467,000 | +64.4% | 2,750 | +52.8% | 0.03% | +62.5% |
Q2 2021 | $284,000 | +13.6% | 1,800 | 0.0% | 0.02% | +6.7% |
Q1 2021 | $250,000 | -20.6% | 1,800 | 0.0% | 0.02% | -25.0% |
Q4 2020 | $315,000 | +21.6% | 1,800 | +35.8% | 0.02% | +5.3% |
Q3 2020 | $259,000 | +13.1% | 1,325 | -1.5% | 0.02% | +5.6% |
Q2 2020 | $229,000 | – | 1,345 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |